EIAP Aims to Facilitate the Advancement of Scientists from Diverse Backgrounds

Accepting Applications Until December 31

 Join the Information Session, December 9, 4-5 pm

Join the webinar at this link.

With the support of the National Cancer Institute's (NCI) Equity Council, NCI is launching the Early Investigator Advancement Program (EIAP) to facilitate the advancement of scientists from diverse backgrounds to become independent investigators.

The cancer research enterprise needs a continuous flow of talent through the research career pipeline to thrive. One critical juncture is the transition from junior investigator to independent investigator. Each year, EIAP will support the professional and career development of a cohort of eligible and qualified Early Stage Investigators and New Investigators from institutions across the country.

EIAP aims to:

• Enhance professional skills;
• Guide preparation of an R01 grant application;
• Provide access to a mentoring and peer network; and
• Grow a community of emerging independent investigators from diverse backgrounds.

EIAP will hold a pre-application webinar tomorrow, December 9, 2021, from 4:00-5:00 pm EST. Join the webinar at this link.

Applications to the EIAP must be submitted by December 31, 2021. The target start date will be March 1, 2022. Potential applicants should visit the EIAP webpage for information about eligibility, application instructions and more.

NCI values diversity and particularly encourages applicants from populations underrepresented in the biomedical sciences, as noted in the Notice of NIH's Interest in Diversity (NOT-OD-20-031).

Questions? Contact Dr. Alison Lin, EIAP@nih.gov.